Opko Health OPK
NASDAQ OPK
$1.73 +0.03 (+2.07%)
As of: Sep 22, 2026 · 11:37 AM EDT

Opko Health (OPK) Other Accumulated Expenses (2022 - 2026)

Opko Health's (OPK) quarterly Other Accumulated Expenses came in at $19.3 million in Q2 2026, up 9.17% on a YoY basis from $17.7 million in Q2 2025, and up 5.66% quarter-over-quarter from $18.3 million in Q1 2026.

Analysis

Opko Health (OPK) Other Accumulated Expenses (2022 - 2026) Analysis & Trends

Opko Health (OPK) has reported Other Accumulated Expenses for 5 consecutive years, with $19.3 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Other Accumulated Expenses rose 9.17% year-over-year to $19.3 million; the trailing twelve-month figure through Jun 2026 stood at $19.3 million (up 9.17% YoY), and the FY2025 full-year result was $18.3 million, down 18.2% from the prior year.
  • Other Accumulated Expenses improved to $19.3 million in Q2 2026 per OPK's latest filing, from $18.3 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $40.1 million in Q2 2023 and bottomed at $17.7 million in Q2 2025.
  • Historically, Other Accumulated Expenses has averaged $23.7 million across 5 years, with a median of $21.4 million in 2023.
  • The sharpest annual moves came in 2024 and 2025: Other Accumulated Expenses advanced 9.21% in 2024, then plunged 42.5% in 2025.
  • Over 5 years, Other Accumulated Expenses stood at $27.4 million in 2022, then decreased by 24.36% to $20.7 million in 2023, then climbed by 8.13% to $22.4 million in 2024, then dropped by 18.2% to $18.3 million in 2025, then gained by 5.42% to $19.3 million in 2026.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods registered $19.3 million, $18.3 million, and $18.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn
10 Opko Health 1.25 Bn 945.61 Mn 80.02 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 19.30 Mn
Mar 31, 2026 18.27 Mn
Dec 31, 2025 18.31 Mn
Sep 30, 2025 17.97 Mn
Jun 30, 2025 17.68 Mn
Mar 31, 2025 19.11 Mn
Dec 31, 2024 22.39 Mn
Sep 30, 2024 31.25 Mn
Jun 30, 2024 28.24 Mn
Mar 31, 2024 22.05 Mn
Dec 31, 2023 20.70 Mn
Sep 30, 2023 28.62 Mn
Jun 30, 2023 40.14 Mn
Dec 31, 2022 27.37 Mn
API Access

Opko Health Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=OPK&period=max&api_key=YOUR_API_KEY